Synbiotic Supplementation Containing Whole Plant Sugar Cane Fibre and Probiotic Spores Potentiates Protective Synergistic Effects in Mouse Model of IBD.
Tanvi ShindeAgampodi Promoda PereraRavichandra VemuriShakuntla V GondaliaAvinash V KarpeDavid J BealeSonia ShastriBenjamin SouthamRajaraman EriRoger StanleyPublished in: Nutrients (2019)
Inflammatory bowel diseases (IBD) are a chronic inflammatory disorders with increasing global incidence. Synbiotic, which is a two-point approach carrying probiotic and prebiotic components in mitigating inflammation in IBD, is thought to be a pragmatic approach owing to the synergistic outcomes. In this study, the impacts of dietary supplementation with probiotic Bacillus coagulans MTCC5856 spores (B. coagulans) and prebiotic whole plant sugar cane fibre (PSCF) was assessed using a murine model of IBD. Eight-week-old C57BL/6 mice were fed a normal chow diet supplemented with either B. coagulans, PSCF or its synbiotic combination. After seven days of supplementation, colitis was induced with dextran sulfate sodium (DSS) in drinking water for seven days during the continuation of the supplemented diets. Synbiotic supplementation ameliorated disease activity index and histological score (-72%, 7.38, respectively), more effectively than either B. coagulans (-47%, 10.1) and PSCF (-53%, 13.0) alone. Synbiotic supplementation also significantly (p < 0.0001) prevented the expression of tight junction proteins and modulated the altered serum IL-1β (-40%), IL-10 (+26%), and C-reactive protein (CRP) (-39%) levels. Synbiotic supplementations also raised the short-chain fatty acids (SCFA) profile more extensively compared to the unsupplemented DSS-control. The synbiotic health outcome effect of the probiotic and prebiotic combinations may be associated with a synergistic direct immune-regulating efficacy of the components, their ability to protect epithelial integrity, stimulation of probiotic spores by the prebiotic fibre, and/or with stimulation of greater levels of fermentation of fibres releasing SCFAs that mediate the reduction in colonic inflammation. Our model findings suggest synbiotic supplementation should be tested in clinical trials.
Keyphrases
- drinking water
- bacillus subtilis
- disease activity
- oxidative stress
- ulcerative colitis
- clinical trial
- rheumatoid arthritis
- lactic acid
- systemic lupus erythematosus
- mouse model
- healthcare
- public health
- cancer therapy
- physical activity
- fatty acid
- mental health
- poor prognosis
- metabolic syndrome
- type diabetes
- risk factors
- ankylosing spondylitis
- diabetic rats
- risk assessment
- health information
- binding protein
- health risk assessment
- open label
- long non coding rna
- social media
- heavy metals
- phase ii